Skip to main content

Table 1 Baseline descriptive statistics of the sample

From: A structural equation model to assess the pathways of body adiposity and inflammation status on dysmetabolic biomarkers via red cell distribution width and mean corpuscular volume: a cross-sectional study in overweight and obese subjects

Variable

Women (137)

Men (29)

Total (166)

 

mean ± sd

mean ± sd

mean ± sd

age (years)

38.92 ± 10.48

41.55 ± 9.53

39.38 ± 10.34

Adiposity markers

 Body weight (kg)*

75.80 ± 10.11

94.90 ± 13.09

79.13 ± 12.89

 Body Mass Index (kg/m2)*

29.70 ± 3.11

31.65 ± 3.67

30.04 ± 3.29

 Waist circumference (cm)*

98.88 ± 8.96

109.31 ± 9.75

100.70 ± 9.91

Inflammation markers

 CRP (mg/dl) *

0.43 ± 0.52

0.26 ± 0.21

0.40 ± 0.48

 Reactive Oxygen Species (mg/dl)*

31.71 ± 5.92

29.38 ± 3.57

31.30 ± 5.64

 Slope (fluorescence units/min)

1.26 ± 0.28

1.23 ± 0.20

1.26 ± 0.26

 Lag-time (min)

137.52 ± 18.86

141.90 ± 13.17

138.29 ± 18.04

Red Blood markers

 Red blood cell distribution width (%)*

14.48 ± 1.96

15.32 ± 1.32

14.63 ± 1.89

 Mean Corpuscular Volume (femtoliters)

89.11 ± 3.84

89.39 ± 2.55

89.15 ± 3.65

Dysmetabolic markers (outcomes)

 Systolic Blood Pressure (mmHg)

132.89 ± 11.00

135.69 ± 7.27

133.38 ± 10.48

 Diastolic Blood Pressure (mmHg)

81.52 ± 4.38

83.45 ± 5.01

81.86 ± 4.55

 Blood glucose level (mmol/l)

5.01 ± 0.90

5.06 ± 0.59

5.02 ± 0.85

 Insulin (mUI/L)

8.24 ± 3.69

9.07 ± 5.01

8.38 ± 3.95

 HOMA (units)

1.81 ± 0.84

2.04 ± 1.16

1.85 ± 0.90

 Triglycerides (mmol/l)

1.04 ± 0.53

1.27 ± 0.77

1.08 ± 0.58

 Total Cholesterol (mmol/l)

5.27 ± 1.01

5.46 ± 1.14

5.31 ± 1.03

 HDL Cholesterol (mmol/l)*

1.56 ± 0.36

1.36 ± 0.35

1.52 ± 0.37

 LDL cholesterol (mmol/l)

3.11 ± 0.89

3.52 ± 1.04

3.19 ± 0.92

 Total Cholesterol/HDL Cholesterol (units)*

3.45 ± 1.02

4.27 ± 1.44

3.60 ± 1.14

  1. Data are expressed as mean ± standard deviation
  2. *Statistically significant differences (T test or Mann-Whitney test, P < 0.05) between women and men
  3. CRP C-Reactive Protein, ROS Reactive Oxygen Species, HOMA Homeostasis Model Assessment, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol